Latest News for NCNA
EDINBURGH, United Kingdom, Jan. 06, 2026 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) (“NuCana” or the “Company”), a clinical-stage biopharmaceutical company focused on improving treatment outcomes for patients with cancer, announced the appointment of Theresa Bruce as Chief Operating Officer, effective January 1, 2026.
Data Presented at ESMO IO 2025 include Partial Responses, Durable Disease Control, and No New Safety Signals, Reinforcing Earlier Findings Data Presented at ESMO IO 2025 include Partial Responses, Durable Disease Control, and No New Safety Signals, Reinforcing Earlier Findings
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for NCNA.
Senate Trading
No Senate trades found for NCNA.
U.S. House Trading
No House trades found for NCNA.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.